These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1294489)

  • 1. Prophylactic theophylline infusion for prevention of apnea of prematurity.
    Merchant RH; Sakhalkar VS; Ashavaid TF
    Indian Pediatr; 1992 Nov; 29(11):1359-63. PubMed ID: 1294489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theophylline infusion for prevention of apnea of prematurity.
    Rao R; Narang A
    Indian Pediatr; 1993 Jun; 30(6):823-5. PubMed ID: 8132273
    [No Abstract]   [Full Text] [Related]  

  • 3. Theophylline concentration following equal doses of intravenous aminophylline and oral theophylline in preterm infants.
    al-Omran A; al-Alaiyan S
    Am J Perinatol; 1997 Mar; 14(3):147-9. PubMed ID: 9259917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
    Skouroliakou M; Bacopoulou F; Markantonis SL
    J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of theophylline in apnea of prematurity in small for gestational age babies.
    Chaudhuri M; Garg SK; Narang A; Bhakoo ON
    Indian Pediatr; 1996 Mar; 33(3):181-7. PubMed ID: 8772836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea.
    Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of apnea and bradycardia in low-birthweight infants.
    Shannon DC; Gotay F; Stein IM; Rogers MC; Todres ID; Moylan FM
    Pediatrics; 1975 May; 55(5):589-94. PubMed ID: 236535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of salivary theophylline in monitoring the treatment for apnoea of prematurity.
    Chereches-Panta P; Nanulescu MV; Culea M; Palibroda N
    J Perinatol; 2007 Nov; 27(11):709-12. PubMed ID: 17717520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the efficacy and safety of aminophylline in treatment of apnea of prematurity in neonatal intensive care unit.
    Ye C; Miao C; Yu L; Dong Z; Zhang J; Mao Y; Lu X; Lyu Q
    Pediatr Neonatol; 2019 Feb; 60(1):43-49. PubMed ID: 29673564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy and reliability of dosing equations to individualize theophylline treatment of apnea of prematurity.
    Bhatt-Mehta V; Johnson CE; Donn SM; Spadoni V; Schork MA
    Pharmacotherapy; 1995; 15(2):246-50. PubMed ID: 7624272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative study about the therapeutic effect of theophylline and doxapram in apnoeic disorders].
    Möller JC; Austing A; Püst B; Kohl M; Reiss I; Iven H; Gortner L
    Klin Padiatr; 1999; 211(2):86-91. PubMed ID: 10407818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of two dosing equations for theophylline in premature infants.
    Bhatt-Mehta V; Donn SM; Schork MA; Reed S; Johnson CE
    Pharmacotherapy; 1996; 16(5):769-76. PubMed ID: 8888073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic, hormonal and nutritional effects of long-term theophylline therapy in preterm infants: a case-control study].
    Colonna F; Pahor T; de Vonderweid U; Radillo L; Tamaro G
    Pediatr Med Chir; 1995; 17(4):345-8. PubMed ID: 7491331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose doxapram for apnea unresponsive to aminophylline in very low birthweight infants.
    Brion LP; Vega-Rich C; Reinersman G; Roth P
    J Perinatol; 1991 Dec; 11(4):359-64. PubMed ID: 1770394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preventive treatment with theophylline of apnea in premature infants: clinical, pharmokinetic and neurophysiological study].
    Demarquez JL; Brachet-Lierman A; Paty J; Deliac MM; Philippe JC; Maix M; Babin JP; Martin C
    Arch Fr Pediatr; 1978; 35(7):793-805. PubMed ID: 736736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring theophylline in premature newborn infants].
    Closa RM; Tarres Roure A; Gómez Papi A; Casasin Edo T
    An Esp Pediatr; 1989 Apr; 30(4):269-71. PubMed ID: 2742236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies.
    Jones RA; Baillie E
    Arch Dis Child; 1979 Mar; 54(3):190-3. PubMed ID: 434904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting theophylline pharmacokinetics in premature infants with apnea.
    Hilligoss DM; Jusko WJ; Koup JR; Giacoia G
    Dev Pharmacol Ther; 1980; 1(1):6-15. PubMed ID: 7438966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of caffeine and theophylline in the neonate.
    Soyka LF; Neese AL; Main D; Main E
    Semin Perinatol; 1981 Oct; 5(4):332-6. PubMed ID: 7302608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn.
    Latini R; Assael BM; Bonati M; Caccamo ML; Gerna M; Mandelli M; Marini A; Sereni F; Tognoni G
    Eur J Clin Pharmacol; 1978 May; 13(3):203-7. PubMed ID: 668774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.